Reach Us +44-1202-068036
Antimicrobial Stewardship Program In KSA: Experiences And Vision Future | 37455
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Antimicrobial stewardship program in KSA: Experiences and vision future

Pharma Middle East

Yousef A Alomi

Ministry of Health, KSA

ScientificTracks Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X.C1.013

Antimicrobial stewardship is continuous work to optimize antimicrobial usage to improve patient outcomes and prevent antimicrobial related problems. General administration of pharmaceutical care established the program in 2013 by formulate Central Antibiotic Committees, this committee established antimicrobial stewardship program consisting of formulating peripheral antibiotics, infectious diseases team, antibiotics physician order form, antibiotics consumption and usages, antibiogram regulation and USA general of disease control antimicrobial stewardship monitoring outcome indicators. In 2014, Peripheral Antibiotics Committees was established in twenty regions to follow up the program implementation, and antimicrobial stewardship education and orientation was started. In 2015, the real applications of the program were started in more than ten regions and forty hospitals. Antimicrobial stewardship will be expanded to cover 20 regions and 90 biggest hospitals, medical cities, private hospitals and primary care centers in KSA. In this talk, I share experiences of our program, and the changes that faced during the program, and strategies to implement it to all Middle East countries.

Yousef A Alomi is the Head of General Administration of Pharmaceutical Care Administration, and Head of National Drug Information Center, MOH KSA. He obtained Bachelor of Pharmaceutical Sciences degree from King Saud University in the year 1992. After six-years of higher study, he earned his Master of Clinical Pharmacy from the same University in the year 1998. He is an affiliated Clinical Instructor of Purdue University in the USA. He is adjunct Assistant Professor of King Saud University College of Pharmacy. He was a member of Pharmacy Board at Saudi Commission for Health Specialties for 1998-2002 and 2008-2012 and Head of Pharmacy Accreditation Committee during 2010-2012. In the year 2005, he obtained Board Certification of Pharmacotherapy Specialist (BCPS). In the year 2008, he obtained his Diploma in Business Administration from American University in Egypt, and Board Certification of Nutrition Support Pharmacy (BCNSP) in 2009. He worked as Clinical Pharmacist in critical care area and nutrition support. He had established and implemented several programs at MOH Hospitals including Clinical Pharmacy Program, Medication Safety Program, Pain Management Program, Anticoagulation Program and Pharmacy Infection Control, and 30 Adult & 20 Pediatrics Clinical Pharmacy Programs. He is the Founder of Mass Gathering Pharmaceutical Care in KSA. He became a member of advisory board of the Arab Pharmaceutical Journal in 2010. He became as Pharmacy Board Member of Saudi Commission of Health Care Specialties (2010-2013). He had conducted several researches and presented at various conferences in Clinical Pharmacy and Pharmacy Practice which were published in ACCP and ISPOR conferences.

Email: [email protected] [email protected]